Angiotensin II human-13C6,15N TFA

• CAT Number: I041378
• Molecular Formula: C4613C6H72F3N1215NO14
• Molecular Weight: 1167.15
• Purity: ≥95%
• Synonyms: (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl](15N)amino]-3-(113C)methyl-1-oxo(1,2,3,4,5-13C5)pentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid;2,2,2-trifluoroacetic acid
• InChI: InChI=1S/C50H71N13O12.C2HF3O2/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66;3-2(4,5)1(6)7/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55);(H,6,7)/t28-,33-,34-,35-,36-,37-,38-,40-,41-;/m0./s1/i1+1,4+1,5+1,28+1,41+1,47+1,59+1
• InChIKey: FYMJZKAYBCZPKL-BNRKCBJISA-N
• SMILES: CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[13C@@H]([13C@@H]([13CH3])[13CH2][13CH3])[13C](=O)[15NH][C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N.C(=O)(C(F)(F)F)O

Angiotensin II human-13C6,15N TFA（Cat No.:I041378）is a deuterated and nitrogen-labeled form of the naturally occurring peptide hormone Angiotensin II, where six hydrogen atoms are replaced by carbon-13, and nitrogen isotopes are incorporated. This modification enhances its stability and allows for precise tracking and analysis in research, particularly in studies focused on the renin-angiotensin system. As a potent vasoconstrictor, Angiotensin II regulates blood pressure and fluid balance. The TFA (trifluoroacetate) salt form improves its solubility, making it suitable for various analytical techniques in cardiovascular and metabolic research.